{
    "clinical_study": {
        "@rank": "120851", 
        "arm_group": {
            "arm_group_label": "SEARCH Study Group"
        }, 
        "brief_summary": {
            "textblock": "The objectives of this study are to investigate the influence on HR-QOL (SF-36 v2) resulting\n      from the compliance of MUCODYNE Tablets or MUCODYNE DS (Dry Syrup) 50% in asthma patients\n      whose control levels are partly controlled or uncontrolled."
        }, 
        "brief_title": "Survey on the Effect of Health Related Quality of Life (QOL) Associated With Compliance of Carbocisteine in Asthma Patients", 
        "completion_date": {
            "#text": "January 2013", 
            "@type": "Actual"
        }, 
        "condition": "Asthma", 
        "condition_browse": {
            "mesh_term": "Asthma"
        }, 
        "detailed_description": {
            "textblock": "Period: 2012-2013 Observation Time: 0 week, 4 week\n\n      Matters investigated:\n\n        1. QOL determination using SF-36 v2\n\n        2. Medication compliance (VAS scale)\n\n        3. Gender, age, diagnosis, asthma subtype, severity, duration of disease, level of asthma\n           control, concomitant drugs, comorbidities, smoking, alcohol, work"
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  Male and female patients \u2265 20 years of age\n\n          -  Outpatients\n\n          -  Patients with mild or moderate persistent asthma\n\n          -  Patients with phlegm\n\n          -  Patients whose levels of asthma control are partly controlled or uncontrolled\n\n          -  Patients who are planned to treat MUCODYNE\n\n          -  Patients who voluntarily submitted written consent forms upon participation in this\n             study\n\n        Exclusion Criteria:\n\n          -  Patients with a history of adverse reactions to carbocisteine\n\n          -  Patients with serious cardiac, hepatic, renal, pulmonary, or hematological disease\n\n          -  Patients with the possibility of pregnancy or suspected pregnancy\n\n          -  Patients with complication of malignancy\n\n          -  Current smoker\n\n          -  Patients with definitive diagnosis for COPD\n\n          -  Other patients whom investigators or subinvestigators considered inappropriate to\n             participate in this study"
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "N/A", 
            "minimum_age": "20 Years", 
            "sampling_method": "Probability Sample", 
            "study_pop": {
                "textblock": "General Practitioner"
            }
        }, 
        "enrollment": {
            "#text": "179", 
            "@type": "Actual"
        }, 
        "firstreceived_date": "September 21, 2012", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01693471", 
            "org_study_id": "SEARCH-2012"
        }, 
        "intervention_browse": {
            "mesh_term": "Carbocysteine"
        }, 
        "is_fda_regulated": "No", 
        "keyword": [
            "asthma", 
            "SF-36", 
            "HRQOL"
        ], 
        "lastchanged_date": "February 27, 2013", 
        "location": {
            "facility": {
                "address": {
                    "city": "Ota-ku", 
                    "country": "Japan", 
                    "state": "Tokyo", 
                    "zip": "145-0063"
                }, 
                "name": "Senzoku Respiratory Disease and Allergy Clinic"
            }
        }, 
        "location_countries": {
            "country": "Japan"
        }, 
        "number_of_groups": "1", 
        "official_title": "Survey on the Effect of Health Related QOL Associated With Compliance of Carbocisteine in Asthma Patients Study (SEARCH Study)", 
        "overall_official": {
            "affiliation": "Kyorin Pharmaceutical Co.,Ltd", 
            "last_name": "Akito Saegusa, Mr.", 
            "role": "Study Chair"
        }, 
        "overall_status": "Completed", 
        "oversight_info": {
            "authority": "Japan: Institutional Review Board", 
            "has_dmc": "No"
        }, 
        "phase": "N/A", 
        "primary_completion_date": {
            "#text": "December 2012", 
            "@type": "Actual"
        }, 
        "primary_outcome": {
            "measure": "Score of SF-36", 
            "safety_issue": "No", 
            "time_frame": "4 week"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01693471"
        }, 
        "responsible_party": {
            "responsible_party_type": "Sponsor"
        }, 
        "secondary_outcome": [
            {
                "measure": "HR-QOL condition of asthma patients with phlegm", 
                "safety_issue": "No", 
                "time_frame": "0 week"
            }, 
            {
                "measure": "Medication compliance: measured by patient response to visual analog scale", 
                "safety_issue": "No", 
                "time_frame": "4 week"
            }, 
            {
                "measure": "Relation between a medication compliance measured by patient response to visual analog scale and change of HR-QOL from baseline at 4 weeks", 
                "safety_issue": "No", 
                "time_frame": "0 week, 4 week"
            }
        ], 
        "source": "Kyorin Pharmaceutical Co.,Ltd", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "Kyorin Pharmaceutical Co.,Ltd", 
                "agency_class": "Industry"
            }
        }, 
        "start_date": "September 2012", 
        "study_design": "Observational Model: Cohort, Time Perspective: Prospective", 
        "study_type": "Observational", 
        "verification_date": "February 2013"
    }
}